TP53 and acute myeloid leukemia: However, there is heterogeneity in TP53-mutant AML based on types of mutations, involved domains, and VAF; a recent report found that patients without abnormal p53 protein expression, intact copy number, and low VAF had a more favorable prognosis in the spectrum of TP53-mutant AML [66].